Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Neisseria Gonorrhoeae Tests Market Report Overview
The Neisseria Gonorrhoeae Tests market size was valued at $383.7 million in 2022. Neisseria Gonorrhoea is one of the most common sexually transmitted diseases (STD) worldwide, caused by the bacteria Neisseria gonorrhoea. N. gonorrhoea infections are more common in young adults. Other groups at higher risk of contracting gonorrhoea include individuals with multiple sexual partners, individuals with another STD, men having sex with men (MSM), and sex workers. Increases in the incidence of Neisseria gonorrhoea infections are likely due in part, to a greater number of individuals being screened as well as the advent of improved screening techniques like Neisseria Gonorrhoea Nucleic Acid Amplification (NAAT) Tests, which are highly sensitive and specific.
Neisseria Gonorrhoeae Tests Market Outlook 2022-2033 ($ Million)
For more insights on the Neisseria Gonorrhoeae Tests market forecast, download a free sample report
The Neisseria Gonorrhoeae Tests market research report is built to visualize quantitative market trends within in vitro diagnostics therapeutic areas. Furthermore, the model discusses in detail the impact of COVID-19 on the Neisseria Gonorrhoeae Tests market for the year 2020 and beyond.
Market Size (2022) | $383.7 million |
Historic Period | 2015-2022 |
Forecast Period | 2023-2033 |
Key Segments |
|
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Neisseria Gonorrhoeae Tests Market Dynamics
The Neisseria Gonorrhoeae (NG) tests market is expected to increase during the forecast period, largely due to sales increases in France, Spain, Australia, China, and India. In North America, Europe and Asia-Pacific, growth is expected to occur in selected countries. The increasing incidences of Gonorrhoeae and opportunistic screening tests provided by healthcare facilities are major drivers for the Neisseria Gonorrhoeae tests market. However, factors that are expected to negatively impact the Neisseria Gonorrhoeae tests market include changes to sexual and reproductive health service provision, switches in device usage, and decline in live birth rates.
For additional Neisseria Gonorrhoeae Tests market dynamics, download a free sample report
Neisseria Gonorrhoeae Tests Market Segments
The key segments in the Neisseria Gonorrhoeae Tests market are Dual CT/NG Nucleic Acid Amplification Tests, Neisseria Gonorrhoeae Nucleic Acid Amplification Tests (NAATs), and Other Neisseria Gonorrhoeae Tests. In 2022, the Dual CT/NG Nucleic Acid Amplification Tests segment dominated the market share.
The preferred method of screening for genital Neisseria Gonorrhoeae is via NAATs. This technique is used in laboratories across most countries and is generally considered superior to other tests such as the culture method. Furthermore, dual-testing NAATs can be used to simultaneously screen for Chlamydia Trachomatis and Neisseria Gonorrhoeae infections together, thus improving the detection rates of these two sexually transmitted diseases. NAATs can be cost-effective while also providing optimum results due to the pooling of samples. Specimens screened using NAAT are not sent for confirmatory testing and the NAAT results are considered definitive.
Neisseria Gonorrhoeae Tests Market Analysis by Segments, 2022 (%)
To know more about the Neisseria Gonorrhoeae Tests market segments, download a free sample report
Neisseria Gonorrhoeae Tests Market Segmentation by Regions
The key regions in the Neisseria Gonorrhoeae Tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2022, North America emerged as the leading regional segment.
The Neisseria Gonorrhoeae (NG) tests market is expected to grow across all North American countries during the forecast period, with the strongest growth being forecast in the US and Canada. The growth of the US and Canadian NG test markets is largely being driven by increases in the number of infection and suspected infection cases. Sales of NG tests in these countries are also bolstered by a high proportion of pregnant women undergoing NG screening. As such, increases in live birth rates are also expected to contribute to market growth. In all North American countries, sources indicate that the majority of Neisseria gonorrhoeae infection screening is performed via dual CT/NG NAAT and the trend is expected to continue during the projected period.
Neisseria Gonorrhoeae Tests Market Analysis by Regions, 2022 (%)
For more regional insights in the Neisseria Gonorrhoeae Tests market, download a free sample report
Neisseria Gonorrhoeae Tests Market – Competitive Landscape
The key companies in the Neisseria Gonorrhoeae Tests market are Abbott Laboratories, Becton Dickinson and Co, ZeptoMetrix Corporation, Danaher Corp, F. Hoffmann-La Roche Ltd, Hologic Inc, Thermo Fisher Scientific Inc, and others. In 2022, Thermo Fisher Scientific Inc accounted for the highest Neisseria Gonorrhoeae Tests market share and value.
Neisseria Gonorrhoeae Tests Market Analysis by Companies, 2022 (%)
For more company insights into the Neisseria Gonorrhoeae Tests market, download a free sample report
Segments Covered in this Report
Neisseria Gonorrhoeae Tests Segment Outlook ($ Million, 2015-2033)
- Dual CT/NG Nucleic Acid Amplification Tests
- Neisseria Gonorrhoeae Nucleic Acid Amplification Tests (NAATs)
- Other Neisseria Gonorrhoeae Tests
Neisseria Gonorrhoeae Tests Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are –
Currently marketed Neisseria Gonorrhoeae Tests market and evolving competitive landscape –
- Insightful review of the key industry trends.
- Annualized total Neisseria Gonorrhoeae Tests market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional and Country level market specific insights –
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Neisseria Gonorrhoeae Tests market.
- Competitive dynamics insights and trends provided for the Neisseria Gonorrhoeae Tests market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Becton Dickinson and Co, ZeptoMetrix Corporation, Danaher Corp, F. Hoffmann-La Roche Ltd, Hologic Inc, Thermo Fisher Scientific Inc, and others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for
- CMO executives who must have a deep understanding of the Neisseria Gonorrhoeae Tests marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to –
- Understand the impact of COVID-19 on Neisseria Gonorrhoeae Tests.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving Neisseria Gonorrhoeae Tests.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neisseria Gonorrhoeae Tests market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Neisseria Gonorrhoeae Tests market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Becton Dickinson and Co
ZeptoMetrix Corporation
Danaher Corp
F. Hoffmann-La Roche Ltd
Hologic Inc
Thermo Fisher Scientific Inc
Frequently asked questions
-
What was the Neisseria Gonorrhoeae Tests market size in 2022?
The Neisseria Gonorrhoeae Tests market size was $383.7 million in 2022.
-
Which was the leading segment in the Neisseria Gonorrhoeae Tests market?
Dual CT/NG Nucleic Acid Amplification Tests segment was leading the Neisseria Gonorrhoeae Tests market in 2022.
-
Which region dominates the Neisseria Gonorrhoeae Tests market?
North America held the largest share of the Neisseria Gonorrhoeae Tests market in 2022.
-
Who are the market players in the Neisseria Gonorrhoeae Tests market?
The key companies in the Neisseria Gonorrhoeae Tests market are Abbott Laboratories, Becton Dickinson and Co, ZeptoMetrix Corporation, Danaher Corp, F. Hoffmann-La Roche Ltd, Hologic Inc, Thermo Fisher Scientific Inc, and others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.